A detailed history of Tectonic Advisors LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Tectonic Advisors LLC holds 3,891 shares of JAZZ stock, worth $473,340. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,891
Previous 3,659 6.34%
Holding current value
$473,340
Previous $390,000 11.03%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$100.57 - $116.37 $23,332 - $26,997
232 Added 6.34%
3,891 $433,000
Q2 2024

Aug 02, 2024

BUY
$103.94 - $118.98 $44,590 - $51,042
429 Added 13.28%
3,659 $390,000
Q1 2024

May 07, 2024

BUY
$115.19 - $132.77 $62,202 - $71,695
540 Added 20.07%
3,230 $388,000
Q4 2023

Jan 17, 2024

BUY
$114.26 - $136.0 $32,335 - $38,488
283 Added 11.76%
2,690 $330,000
Q3 2023

Oct 23, 2023

BUY
$122.0 - $145.31 $293,654 - $349,761
2,407 New
2,407 $311,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.63B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Tectonic Advisors LLC Portfolio

Follow Tectonic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tectonic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tectonic Advisors LLC with notifications on news.